Skip to main content
Distinctive Mark™Trademark News & Analysis

Naming a product by its defining technique can make the name generic

The marks at issue
Applicant · Serial No. · 90881906PULSE DECOMPOSITION ANALYSIS (standard characters; Supplemental Register)Patient monitoring sensors and monitors for physiological parameters, with software for recording, processing and transmitting medical data sold as a unit, International Class 10

A term need not be what buyers call the product to be generic for it. The Board keeps holding that naming a key aspect or subcategory of the goods is enough, and in this non-precedential decision it applied that rule to the name of a measurement method that defines a type of device (at 4, 12–14). Being the only user does not help: competitor use is relevant if it exists, but not required when other evidence shows how the public understands the term (at 14).

The limit is the evidence. The phrase had a settled meaning in technical literature, and it named the feature that sets this type of monitor apart. In practice, amending to the Supplemental Register concedes the term is not inherently distinctive, leaving genericness as the only question (at 7). The applicant's own patent, manuals and website, which used the phrase as the name of a method, counted against it (at 10–12). In the editors' view, a company that names a new technology should put a separate brand on the device rather than expect to own the technology's name.

The case: PULSE DECOMPOSITION ANALYSIS for patient monitors and sensors, with healthcare professionals as the relevant public (at 5–6). Articles from SPIE, IEEE, the Journal of Hypertension and PubMed described the phrase as a non-invasive way to estimate blood pressure from the pulse waveform (at 8–10). The refusal was affirmed.

Data angle: most of the record came from technical literature, supported by the applicant's own materials. For a product named after a method, the peer-reviewed record can decide genericness.

Filed underGenericnessSupplemental RegisterMedical devicesEx parte appeals

Report an error in this piece